Amphastar Pharmaceuticals AMPH Operating Lease Right Of Use Assets And Liabilities Net
Operating Lease Right Of Use Assets And Liabilities Net at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept amph:OperatingLeaseRightOfUseAssetsAndLiabilitiesNet.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's operating lease right of use assets and liabilities net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's operating lease right of use assets and liabilities net?
- Amphastar Pharmaceuticals (AMPH) reported operating lease right of use assets and liabilities net of -$1.42M in Q1 2026.
- How has Amphastar Pharmaceuticals's operating lease right of use assets and liabilities net changed year-over-year?
- Amphastar Pharmaceuticals's operating lease right of use assets and liabilities net decreased by 87.7% year-over-year, from -$754K to -$1.42M.
- What is the long-term trend for Amphastar Pharmaceuticals's operating lease right of use assets and liabilities net?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's operating lease right of use assets and liabilities net has grown at a 15.1% compound annual growth rate (CAGR), from -$3.2M to -$5.61M.
- What does operating lease right of use assets and liabilities net mean?
- This metric represents the net cash flow impact or adjustment related to the recognition and settlement of operating lease obligations. It captures the difference between lease expenses recognized in the income statement and the actual cash payments made for lease liabilities. It is essential for reconciling net income to operating cash flow under current lease accounting standards.